Clinical research
Being tested in people in registered clinical trials. Being in trials is not evidence that a treatment works or is safe.
이 임상시험이 검증하는 내용
The trial that started clinical gene editing. Years before CRISPR was a tool, patients with HIV had their own immune cells taken out, had a gene edited with zinc finger nucleases, and had them returned. It showed that a permanent, targeted edit could be made in a patient's cells and given back safely.
A Phase 1 study of autologous CD4 T cells with CCR5 disrupted by zinc finger nucleases in people with HIV. Published in the New England Journal of Medicine, it reported that infusion was safe and that modified cells persisted, establishing the clinical feasibility of therapeutic genome editing.
Sources
- New England Journal of Medicine · 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV ↗
임상시험 결과가 의미하는 것과 의미하지 않는 것
초기 임상 결과는 소수의 참가자와 짧은 추적 관찰 기간에서 얻은 것입니다. 참가자 수와 시간이 늘어나면 결과가 달라질 수 있으며, 모집 중·진행 중·완료된 임상시험이라도 치료 효과가 입증된 것은 아닙니다. 등록 기준은 엄격하며, 참여 자격은 임상시험 기관이 결정하고 웹사이트가 결정하지 않습니다.